Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for Onconetix (ONCO) over the last 2 years, with Q3 2025 value amounting to $34757.0.

  • Onconetix's Cost of Revenue fell 8846.99% to $34757.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $178554.0, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 2390.19% up from last year.
  • As of Q3 2025, Onconetix's Cost of Revenue stood at $34757.0, which was down 8846.99% from $35991.0 recorded in Q2 2025.
  • Onconetix's 5-year Cost of Revenue high stood at $604132.0 for Q2 2024, and its period low was $34757.0 during Q3 2025.